메뉴 건너뛰기




Volumn 17, Issue 4, 2013, Pages 641-650

Development of synthetic routes, via a tropinone intermediate, to a long-acting muscarinic antagonist for the treatment of respiratory disease

Author keywords

[No Author keywords available]

Indexed keywords

BUILDING BLOCKES; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CLINICAL TRIAL; EPOXIDE REDUCTION; REACTION CONDITIONS; SAFETY ASSESSMENTS; SYNTHETIC ROUTES;

EID: 84876517281     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op3002933     Document Type: Article
Times cited : (9)

References (42)
  • 1
    • 0003579421 scopus 로고    scopus 로고
    • World Health Organization: Geneva, Switzerland
    • World Health Report; World Health Organization: Geneva, Switzerland; 2000. See http://www.who.int/whr/2000/en/index.html.
    • (2000) World Health Report
  • 2
    • 84863955301 scopus 로고    scopus 로고
    • From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)
    • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), (2013. Available from: http://www.goldcopd.org.
    • (2013) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.